Argentine President Carlos Menem has refused to modify his country's lawon drug patents, as requested by members of a US Congressional delegation visiting Buenos Aires, reports the Xinhua news agency.
At a meeting last week, President Menem told them that Argentine laws are up to international standards, according to Jorge Campbell, Argentina's Secretary for International Economic Relations. He noted that while the legislators had accepted Argentina's efforts to protect intellectual property rights, "it was obvious that, for them, our law is inferior" to that of the World Trade Organization. The legislation will be "a permanent issue" for discussion on the agenda of both countries, Mr Campbell added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze